Search This Blog

Wednesday, April 17, 2024

Avalo Ex-Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market: OppCo

 Upped to Outperform; target $35.

https://finviz.com/quote.ashx?t=AVTX&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)